2023-08-29T15:04:33-05:00 2022-12-31 135565207 KPMG LLP 345 PARK AVENUE NEW YORK NY 101540102 990PF 2022-01-01 820656623 THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA SILV 9175198108 PO BOX 237137 NEW YORK NY 10023 NATALIE SILVERSTEIN VICE PRES/TREASURER 9175198108 2023-08-25 1 NATALIE SILVERSTEIN 999009999 0 DEVIN L DUNCAN P01249521 2127589700 2023-08-24 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z X X 1476308 X 26818 22257 22257 0 49075 22257 0 0 0 0 0 21304 0 0 21304 20400 0 0 20400 3808 0 0 3558 45512 0 0 45262 1797500 1797500 1843012 0 0 1842762 -1793937 22257 0 3206167 1412230 1412230 71678 64078 64078 3277845 1476308 1476308 18915 18915 18915 18915 X 3258930 1457393 3258930 1457393 3277845 1476308 3258930 -1793937 0 1464993 7600 1457393 309 0 309 0 309 0 0 400 0 400 0 91 91 0 0 0 0 0 0 0 0 0 0 0 1 1 NY 1 0 0 0 0 1 WWW.SILVERSTEINFOUNDATION.ORG JONATHAN T SILVERSTEIN 9175198108 PO BOX 237137 NEW YORK NY 10023 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 JONATHAN SILVERSTEIN PO BOX 237137 NEW YORK NY 10023 PRESIDENT / SECRETARY 2.00 0 0 0 NATALIE SILVERSTEIN PO BOX 237137 NEW YORK NY 10023 VICE PRESIDENT / TREASURER 1.00 0 0 0 GEOFFREY LEVIN PO BOX 237137 NEW YORK NY 10023 BOARD MEMBER 1.00 0 0 0 NONE 0 NONE 0 0 63239 1791825 0 1855064 0 0 1855064 27826 1827238 91362 91362 309 309 91053 0 91053 0 91053 1842762 0 1842762 91053 0 0 0 1842762 0 0 0 91053 1751709 0 0 1751709 0 0 0 0 0 0 0 1751709 1751709 JONATHAN SILVERSTEIN NATALIE SILVERSTEIN THE SILVERSTEIN FOUNDATION FOR PARK PO BOX 237137 NEW YORK NY 10023 9175198108 INFO@SILVERSTEINFOUNDATION.ORG THE FOUNDATION'S BOARD OF TRUSTEES AND SCIENTIFIC ADVISORY COMMITTEE ACCEPT GRANT APPLICATIONS FROM ORGANIZATIONS FOCUSED ON RAPIDLY CONVERTING SCIENTIFIC IDEAS AND EXPERIMENTAL DRUGS INTO FDA APPROVED THERAPEUTICS TO TREAT AND PREVENT THE ONSET OF PARKINSON'S DISEASE IN GBA-MUTATION CARRIERS. THE FOUNDATION REVIEWS QUALIFIED GRANT APPLICATIONS AS RECEIVED. NONE THE NEW YORK STEM CELL FOUNDATION 619 WEST 54TH STREET NEW YORK NY 10019 N/A PC DRUG DISCOVERY FOR PARKINSON'S WITH GBA. 1372500 LYSOWAY THERAPEUTICS 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140 N/A NC EVALUATING THE THERAPEUTIC EFFECTS OF TRPML1 AND TMEM175 AGONISTS ON GBA-DEFICIENT PARKINSON'S DISEASE MODELS. 225000 MICHAEL J FOX FOUNDATION MODAG GRAND CENTRAL STATION PO BOX 4777 NEW YORK NY 10163 N/A PC FOLLOW-UP STUDY OF A DRUG (ANLE138B) - GOAL IS TO STOP THE PARKINSON'S PROTEIN ALPHA-SYNUCLEIN (A-SYN) FROM CLUMPING TOGETHER. 200000 1797500 THE NEW YORK STEM CELL FOUNDATION 619 WEST 54TH STREET NEW YORK NY 10019 N/A PC DRUG DISCOVERY FOR PARKINSON'S WITH GBA 627500 CURASEN THERAPEUTICS 2655 CAMPUS DRIVE SUITE 110 SAN MATEO CA 94403 N/A NC GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY CLIN-015 225000 852500 14 22257 0 22257 0 22257 0 0 0 0 0 0 0 0 0 0 X X 1 PATRICK HERON 405 MARLOWE STREET PALO ALTO CA 94301 10000 X 2 ADAM WOLFSON 358 FIFTH AVENUE 8TH FLOOR NEW YORK NY 10001 5000 X ACCOUNTING FEES 20400 0 0 20400 FORM 990-PF, PART VI-B, LINE 5B AND PART XII PURSUANT TO TREASURY REGULATION 1.170A-9(F)(4)(VII), THE ORGANIZATION IS FILING AN INITIAL RETURN AS A FORMER PUBLIC CHARITY. BECAUSE OF THIS, FOR THE TAX YEAR ENDED DECEMBER 31, 2022 THE ORGANIZATION IS SUBJECT TO IRC SECTION 4940 BUT NOT IRC SECTIONS 4941-4945. ADP AUTOMATIC DATA PROCESSING 9554 9554 IEMG ISHARES INC CORE MSCI EMERGING MKTS ETF 33463 33463 GILD GILEAD SCIENCES INC 13736 13736 OTHER 7325 7325 LEGAL FEES 21304 0 0 21304 UNREALIZED (GAIN) / LOSS 7600 SOFTWARE LICENSE AND SUPPORT 2550 0 0 2550 SERVICE FEES 1008 0 0 1008 STATE CHARITIES FEE 250 0 0 0